In 1985 the Semblers feared civil suits by abuse victims and possible criminal prosecution. They changed the mission of Straight, Inc. from “treatment” to “education” and its name from “Straight, Inc.” to “Straight Foundation, Inc.” Although it may have appeared to close in 1993, the Straight Inc. program continued instead under the guise of the Pathway Family Center and also gave rise to many other derivative residential treatment programs. In 1995, Betty Sembler changed the name of the educational foundation again to the Drug Free America Foundation (DFAF). They changed the corporate mission to be a guide for companies to set up drug-free workplace environments, and they obtained a federal grant. The name was changed to Drug Free America Foundation and another mission was added: to establish national and international drug policy.
Drug Free America Foundation Inc., 5999 Central Ave Ste 301, St Petersburg , FL 33710 Web Address:
http://www.dfaf.org, DFAF states that it does Mental Health, Crisis Intervention / (Alcohol, Drug and Substance Abuse, Dependency Prevention and Treatment). Year Founded: 1978?
, Mission statement: To Prevent Drug Abuse and promote awareness through education.
Today, Straight Inc. has morphed into an organization called the Drug Free America Foundation (DFAF), specialized to help small businesses set up drug-free workplaces, and to promote national and international drug policy. Working with such federal programs as Ready4Work, DFAF still dominates the drug rehabilitation and re-entry social welfare programs. Through the DFAF and other think tanks such as the American Enterprise Institute, Melvin Sembler continues to influence drug policy in this country by promoting public policy that allows coercive and abusive treatment methods.
Ready4Work is a nationally recognized program assisting ex-offenders with re-entry into the community and workforce, effectively leading participants toward a productive life. Operating with a four-pronged approach; case management, life-coaching, job training and job placement assistance, Ready4Work motivates and moves individuals to become productive, responsible citizens within the community. Commitments and strategic partnerships with faith-based organizations, local businesses, community outlets and the judicial system assist to ensure individuals transition successfully back into the community. This collaborative effort means that DFAF policy permeates the welfare to work programs and that persons with ties to DFAF influence and sometimes control these policy choices.
In 2003, President George W. Bush selected Operation New Hope as the pilot site for the Ready4Work program. Applauded by President Bill Clinton in his book, “Giving,” and endorsed by President Barack Obama, Ready4Work is considered by many to be a model program for the nation. Other supporters include current and former City of Jacksonville leaders Mayor John Peyton, Sheriff John Rutherford, Sheriff Nat Glover and former U.S. Secretary of Labor Elaine Chao.
http://www.operationnewhope.com/ready4work/Melvin Sembler is on the board of the AEI or American Enterprise Institute for Public Policy Research, 1150 Seventeenth Street, N.W., Washington, D.C. 20036. The American Enterprise Institute for Public Policy Research (AEI) is a conservative think tank. As an independent non-profit organization it is primarily supported by grants and contributions from foundations, corporations, and individuals. Its headquarters are in Washington, D.C. Some AEI scholars are considered to be among the leading architects of the second Bush administration's public policy. More than twenty AEI scholars and fellows served either in a Bush administration policy post or on one of the many governmental panels and commissions. AEI.org,
http://www.aei.org/.
Board of Trustees
AEI is governed by a Board of Trustees, composed of leading business and financial executives.Kevin B. Rollins, Chairman
Senior Adviser
TPG Capital
Tully M. Friedman, Vice Chairman
Chairman and CEO
Friedman Fleischer & Lowe, LLC
Gordon M. Binder
Managing Director
Coastview Capital, LLC
Arthur C. Brooks
President
American Enterprise Institute
The Honorable Richard B. CheneyHarlan Crow
Chairman and CEO
Crow Holdings
Daniel A. D'Aniello
Co-Founder and Managing Director
The Carlyle Group Note: The Carlyle Group is a global asset management firm, specializing in private equity, based in Washington, D.C. The Carlyle Group operates in four business areas: corporate private equity, real assets, market strategies and fund-of-funds, through its AlpInvest subsidiary. In its 2010 annual report, Carlyle reported assets in excess of $150 billion under management diversified over 84 distinct funds. The firm employs more than 890 employees, including 495 investment professionals, in 20 countries with offices in the Americas, Europe, Asia, and Australia, and its portfolio companies employ more than 415,000 people worldwide. The firm has over 1,300 investment partners in 71 countries. Carlyle Group controls the patent on the Anthrax vaccine, which was given to military personnel and public health workers when the US Congress was mailed the Anthrax letters. Carlyle has been involved in the development of that vaccine since the 1980's - in facilities in South Africa. The vaccine had not successfully gone through the approval process with the FDA prior to its use on active military personnel during the "crisis" of the anthrax biological terrorist attack. The government contract to vaccinate was very lucrative. Carlyle Group is a huge investment bank - has no public stock and is a privately owned entity and thus its corporate decisions are not open to public scrutiny. Carlyle Group has close ties to the Bush family. Carlyle Group is a major arms dealer and defense contractor.
John V. Faraci
Chairman and CEO
International Paper Company
Christopher B. Galvin
Chairman
Harrison Street Capital, LLC
Raymond V. Gilmartin
Harvard Business School
Harvey Golub
Chairman and CEO, Retired
American Express Company ( American Express handles the shipping of urine samples for drug testing to the testing laboratories of the
Drug Proof company)
Note: Drug Proof does all testing for the Department of Transportation in Seattle and in many other US cities. Drug Proof does testing of all "impaired doctors" for the Washington Physicians Health Program, and also testing of police officers in the King County Police Department. Nationwide Drug Proof, a Canadian based company, has cornered the market for drug testing for municipalities - because all testing companies must be approved and listed in the federal public registrar - few are listed and Drug Proof is by far the largest company doing the drug testing for most municipal governments in the U.S.A.)
Robert F. Greenhill
Founder and Chairman
Greenhill & Co. Inc.
Frank J. Hanna
Hanna Capital, LLC
Bruce Kovner
Chairman
Caxton Associates, LP
Marc S. Lipschultz
Partner
Kohlberg Kravis Roberts & Co.
John A. Luke Jr.
Chairman and CEO
MeadWestvaco Corporation
Robert A. Pritzker
President and CEO
Colson Associates, Inc.
J. Peter Ricketts
President and Director
Platte Institute for Economic Research, Inc.
Edward B. Rust Jr.
Chairman and CEO
State Farm Insurance Companies
D. Gideon Searle
Managing Partner
The Serafin Group, LLC
Mel Sembler
Founder and Chairman
The Sembler Company
Wilson H. Taylor
Chairman Emeritus
CIGNA Corporation
William H. Walton
Managing Member
Rockpoint Group, LLC
William L. Walton
Rappahannock Ventures LLC
Marilyn Ware
Ware Family Office
James Q. Wilson
Boston College Pepperdine University
AIE Emeritus Trustees
Willard C. Butcher
Richard B. Madden
Robert H. Malott
Paul W. McCracken
Paul F. Oreffice
Henry Wendt
AIE Officers Arthur C. Brooks
President
David Gerson
Executive Vice President
Jason Bertsch
Vice President, Development
Henry Olsen
Vice President, Director of the National Research Initiative
Danielle Pletka
Vice President, Foreign and Defense Policy Studies
Council of Academic Advisers
AEI's Council of Academic Advisers, chaired by political scientist James Q. Wilson and including distinguished academics from a variety of policy-related fields, advises AEI's president on the Institute's research agenda, publications, and appointments, and each year selects the recipient of the Irving Kristol Award.
James Q. Wilson, Chairman
Boston College and Pepperdine University
Alan J. Auerbach
Robert D. Burch Professor of Economics and Law
University of California, Berkeley
Eliot Cohen
Paul H. Nitze School of Advanced International Studies
Johns Hopkins University
Martin Feldstein
George F. Baker Professor of Economics
Harvard University
Robert P. George
McCormick Professor of Jurisprudence
Director, James Madison Program in American Ideals and Institutions
Princeton University
Gertrude Himmelfarb
Distinguished Professor of History Emeritus
City University of New York
R. Glenn Hubbard
Dean and Russell L. Carson Professor of Finance and Economics
Columbia Business School
John L. Palmer
University Professor and Dean Emeritus
Maxwell School of Citizenship and Public Affairs
Syracuse University
Sam Peltzman
Ralph and Dorothy Keller Distinguished Service Professor of Economics
Booth School of Business
University of Chicago
George L. Priest
John M. Olin Professor of Law and Economics
Yale Law School
Jeremy A. Rabkin
Professor of Law
George Mason University School of Law
Richard J. Zeckhauser
Frank Plumpton Ramsey Professor of Political Economy
Kennedy School of Government
Harvard University
In an effort to test all school children for drugs (often without their parents consent) and thus put them into a DFAF program, the DFAF rolled out the Teen Screen and other programs testing children for drug use and screening for mental illness. The case below shows the influence of the DFAF and the Drug and Alcohol Testing Industry Association (DATIA) which works with the DFAF to increase the use of psychotropic drugs on school children. Most countries of the world - even in Europe and other developed countries - only drug 1-2% of school age children (grades 1-12) but in the U.S.A. - we drug now 20% and if the DATIA and DFAF have their way it would be many more children on life long psychiatric drugs (usually at the tax payers expense).
BOARD OF EDUC. OF INDEPENDENT SCHOOL DIST. NO. 92 OF POTTAWATOMIE COUNTY, OKLAHOMA Petitioner, v. EARLS. June 27, 2002 These are the signers of the Amicus brief in support of drug testing. The signers include: Drug Free America Foundation (DFAF); Robert DuPont who is on DFAF's advisory board; Peter Bensinger (Peter Bensinger is former head of the DEA and is the business partner with Robert DuPont); Julie Murdoch, Esq. (an employee with Bensinger, DuPont & Associates); Bensinger DuPont & Associates, Bethesda, MD; Institute for Behavior & Health, Bethesda, MD (another Robert DuPont company); Institute on Global Drug Policy (a division of DFAF); Eric Voth, MD, Topeka, KS (but Dr. Voth is the director of DFAF's Institute on Global Drug Policy); Ambassador Melvyn Levitsky who has co-authored an article on drug policy with Dr. Eric Voth; Donald Ian Macdonald, M.D. (Straight's former national research director turned White House Drug Czar); Stephanie Haynes of Save Our Society From Drugs TM, (but SOS is a Betty Sembler foundation); Legal Foundation Against Illicit Drugs (an organization founded by Calvina Fay, executive director of DFAF, and others); Otto Hauswirth, M D, of the International Scientific and Medical Forum on Drug Addicts (DFAF's Calvina Fay is director the International Scientific and Medical Forum on Drug Abuse); Carolyn Burns, of Louisville, KY. DFAF's Calvina Fay is a board member and past president of Drug Watch International (DWI). DWI or its International Drug Strategy Institute division includes or has included Robert L. DuPont and Peter Bensinger, Straight's former national research director Donald Ian Macdonald, Straight's former national clinical director Miller Newton and Straight-Springfield's former research director Dr. Richard Schwartz, MD. Straight's former national executive director Bill Oliver is an Honorary Advisor for DWI (he also became director of parent training for P.R.I.D.E.). Joyce Tobias, formerly acting secretary for DWI, used to be a very active Straight parent. Alex Romero, a DWI board member, and Nancy Starr, a DWI delegate, were signers. And, of course, the Drug and Alcohol Testing Industry Association (DATIA) was a signer. You may see the brief itself at this website:
http://www.datia.org/resources/amicusbrief.htm.
See also:
Wes Fager, “Has Operation PAR become the new treatment arm of Drug Free America Foundation? Or: 3 strikes and the 6th Circuit is out!,” TheStraights.net,
http://thestraights.net/articles/op-par-and-dfaf.htmThe Influence of Straight, Inc. (Drug Free America Foundation) On National and International Drug Policy, thestraights.net,
http://www.thestraights.net/pickets/dfa ... -short.doc.
Drug Free America Foundation, formerly known as Straight, Inc. from 1976-1985. DFAF is a 501(c)(3) non-profit organization.Current DFAF Board of Directors Betty S. Sembler, Chair
D. Jay Snyder, Esq., Legal Counsel/Vice Chair
James D. Sewell, Ph.D, Director
James W. Holton, Esq., Director
John E. Stross, Director
Joseph Garcia, Esq., Secretary
Kevin P. Kauffman, Director
Stuart Lasher, Treasurer
Walter P. Loebenberg, President/Vice Chair
William S. Jacobs, Jr., M.D., Director
Current DFAF Advisory BoardAejandro Vassilaqui
Alfred Hoffman, Jr.
Ambassador Melvyn Levitsky
Andrew P. Thomas, Esq.
Christy McCampbell, Deputy Assistant US Department of State, INL
Clayton M. Wilcox, Ph.D., Former Superintendent Pinellas County Schools
Columba Bush, Former First Lady State of Florida (Jeb Bush’s wife)
Daniel Lungren, Esq., Former Attorney General
Darryl Ervin Rouson, Esq., State Representative/Former President NAACP
H. Lee Moffitt, Esq., Former Speaker Florida House of Representatives
Current DFAF Special AdvisorsDavid A. Gross, M.D., FAPA
David G. Evans, Esq.
Eric Voth, M.D., FACP
Ernest Aeschbach, M.D.
Stephanie Haynes
Another DFAF associated organization with worldwide influence is the Drug Prevention Network of the Americas.
Drug Prevention Network of the Americas (DPNA),
http://www.dpna.org/DPNA%20Calvina.html.
Drug Watch International, Drug Watch International, P.O. Box 45218, Omaha, NE 68145-0218, USA,
http://www.drugwatch.org/.
Drug Watch International
BOARD OF DIRECTORSJohn J. Coleman, Ph. D., Virginia, President
Mina Seinfeld de Carakushansky, Brazil, Vice President
Ed Moses, Missouri, Secretary
Susie Dugan, Nebraska, Treasurer
Heitor De Paola, M.D., Brazil
Lee Dogoloff, Delaware
Terrence P. Farley, Esq., New Jersey
Grainne Kenny, Ireland
Margaret L. Petito, Washington, DC
David Risley, Esq., Illinois
Alex J. Romero, Arizona
Wayne Roques, Florida
Geraldine Silverman, New Jersey
Joan Bellm, Founder and Honorary Director, Illinois
Board of Director Summary Bios
Drug Watch International
COUNCIL OF ADVISORSPat Barton, Florida
Daniel Bent, Esq., Hawaii
James M. Ch'ien, M.D., Hong Kong
Dr. Kachit Choopanya, Thailand
C. E. Edwards, Arizona
Chief Ruben Greenberg, South Carolina
Datuk Haji Idris Ibrahim, Dmsm Jsm, Malaysia
Jerry Johansen, Texas
Cliff Kincaid, Maryland
Lt. Col. (USA Ret.) Robert Maginnis, Washington, DC
Gabriel Nahas, M.D., Ph.D., New York
Fred J. Payne, MD, Louisiana
Bill Oliver, Georgia
Maggie Petito, Washington, D.C.
David Risley, Esq., Illinois
Arlene Seal, Ph.D., Pennsylvania
Padma Talcherkar, M.D., FAAP, Illinois
Drug Watch International:
International Drug Strategy InstituteThe International Drug Strategy Institute is a group of physicians, attorneys, educators, law enforcement officials and drug prevention and treatment specialists who provide expertise on national and international drug strategies. The Institute pursues public policy on drug issues consistent with the mission and goals as established by Drug Watch International.
Director, John J. Coleman (VA, USA)
Joseph E. Atchison, Ph.D. (FL, USA)
Joan Bellm (IL, USA)
William M. Bennett, M.D. (OR, USA)
Peter Bensinger (IL, USA)
Daniel A. Bent, Esq. (HI, USA)
Vesta Boswell, (New Zealand)
Daniel Brookoff, M.D., Ph.D. (TN, USA)
Guy A. Cabral, Ph.D. (VA,USA)
Jose Paulo Carneiro (Brazil)
Jose Carranza, M.D. (TX, USA)
Franklin Alcaraz Castillo, (Bolivia)
Katarina Cnattingius, (Sweden)
Beverly Cox (TN, USA)
James L. Curtis, M.D. (NY, USA)
Susan Dalterio, PhD. (TX, USA)
Dr. Luis Alfredo Vidal de Carvalho (Brazil)
Olavo de Carvalho, (Brazil)
Lee I. Dogoloff, LCSW (MD, USA)
Robert L. DuPont, M.D. (MD, USA)
Drew Edwards, M.S. (FL, USA)
Dr. Albu VanEeden (South Africa)
Rachel Ehrenfeld, Ph.D. (NY, USA)
Fanny Feldman, (Mexico)
Guillermo Fernandez, (Argentina)
Gary Fields, Ph.D. (IL, USA)
Mark Gold, M.D. (FL, USA)
K. F. Gunning, M.D. (The Netherlands)
Franziska Haller, M.D. (Switzerland)
Edward Jacobs, M.D., FAAP (WA, USA)
Grainne Kenny, (Ireland)
Dr. Frans Koopmans (The Netherlands)
John Lamp, Esq. (WA, USA)
Janet Lapey, M.D. (MA, USA)
MaLou Lindholm, (Sweden)
John Malouf, (Australia)
Cesar Malpartida, (Peru)
Ian McDonald, M.D. (MD, USA)
Connie Moulton (MA, USA)
Gabriel Nahas, M.D., Ph.D. (NY, USA)
Miller Newton, Ph.D. (FL, USA)
Charles Perkins, (Canada)
Maggie Petito (DC, USA)
Torgny Peterson, (Sweden)
Edwin Petrik, MD (KS, USA)
Tom Pool, DEA (Ret.) (WA, USA)
David Risley, Esq. (IL, USA)
Blanca Rizzo, (Argentina)
Wayne Roques, DEA (Ret.) (FL, USA)
Ove Rosengren, (Sweden)
Richard Schwartz, M.D. (VA, USA)
Arlene B. Seal, Ph.D., (PA, USA)
Botho Simolin, (Finland)
Ulla Skiden, (Sweden)
David Spencer, M.D. (MN, USA)
Alvera Stern, Ed.D. (MD, USA)
Ann Stoker, (England)
Peter Stoker, (England)
Donald Taskin, M.D. (CA, USA)
Forest Tennant, M.D. (CA, USA)
Albu VanEeden, (South Africa)
Paulo Wengorski, (Brazil)
E. Joe Wiese, MS, LPC (TX, USA)
Renee Wijenko, (The Netherlands)
Juan Alberto Yaria, (Argentina)
